Dr. Rashdan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Blvd
Dallas, TX 75390Phone+1 214-645-4673Fax+1 214-645-0078
Education & Training
Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 2013 - 2016- Indiana University School of MedicineResidency, Internal Medicine, 2009 - 2012
Damascus University Faculty of MedicineClass of 2008
Certifications & Licensure
TX State Medical License 2016 - 2026
IN State Medical License 2012 - 2019
Publications & Presentations
PubMed
- 7 citationsA crowded, but still varied, space: brigatinib in anaplastic lymphoma kinase-rearranged non-small cell lung cancer.Sawsan Rashdan, David E. Gerber
Translational Cancer Research. 2017-02-01 - 5 citationsPotential Impact of Revised NCI Eligibility Criteria Guidance: Prior Malignancy Exclusion in Breast Cancer Clinical Trials.Matthew Perez, Caitlin C Murphy, Sandi L Pruitt, Sawsan Rashdan, Asal Rahimi
Journal of the National Comprehensive Cancer Network. 2022-07-01 - 52 citationsDiagnosis and management of pulmonary toxicity associated with cancer immunotherapy.Sawsan Rashdan, John D. Minna, David E. Gerber
The Lancet. Respiratory Medicine. 2018-06-01
Press Mentions
UT Southwestern: Criteria for Clinical Trials Might Be Too StrictDecember 10th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
